The Role of Acetylation in the Regulation of Antimicrobial Peptide Gene Expression in the Human Intestine Natalie Fischer

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Acetylation in the Regulation of Antimicrobial Peptide Gene Expression in the Human Intestine Natalie Fischer The role of acetylation in the regulation of antimicrobial peptide gene expression in the human intestine Natalie Fischer To cite this version: Natalie Fischer. The role of acetylation in the regulation of antimicrobial peptide gene expression in the human intestine. Microbiology and Parasitology. Université Pierre et Marie Curie - Paris VI, 2014. English. NNT : 2014PA066276. tel-01371241 HAL Id: tel-01371241 https://tel.archives-ouvertes.fr/tel-01371241 Submitted on 25 Sep 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Unité de Pathogénie Microbienne Moléculaire THÈSE Présentée à L’Université Pierre et Marie Curie Ecole doctorale : ED515 « Complexité du Vivant » “The role of acetylation in the regulation of antimicrobial peptide gene expression in the human intestine” Par Natalie Fischer Thèse de doctorat de microbiologie Dirigée par Philippe Sansonetti Présentée et soutenue publiquement le 23 Septembre 2014 Devant un jury composé de : ARLET, Guillaume Professeur à l’UMPC (Président du jury) CERF-BENSUSSAN, Nadine DRCE INSERM (Rapporteur) AIT-SI-ALI, Slimane DR2 CNRS (Rapporteur) SANSONETTI, Philippe Professeur au Collège de France (Directeur de Thèse) SPERANDIO, Brice CR1 INSERM (Co-directeur de Thèse) Acknowledgements Acknowledgments First of all, I want to thank Philippe Sansonetti for flying me in from San Francisco to interview and giving me the change to conduct a thesis in his laboratory. I enjoyed very much the scientific discussions, which we shared over my project and his input in my work. Also I want to thank him for the excellent resources concerning working conditions as well as education, which are provided in his lab. I am very thankful to have had the chance to work in the presence of his scientific genius and kindness and I am grateful for his support throughout my thesis and afterwards. I want to thank Brice Sperandio for being my close supervisor for the past years. He guided me with the perfect balance of supervision, helped me settle in into the lab and project in the beginning, and later trusted me to walk on my own feet. I learned a lot from him, in the wet lab, but also concerning scientific writing and preparation of presentations. I am thankful that he respected my opinion and critics, encouraged my ideas and always had my best interest in mind. I am happy to say, that I think we made a good team and he really did a great job with me. I especially want to thank everybody who agreed to be on my thesis jury, for their time and interest in my work. Special thanks go to Nadine Cerf-Bensussan and Slimane Ait-Si-Ali for taking the time to read and correct my work and to Guillaume Arlet, who kindly accepted to be the president of my jury. I am very much looking forward to discuss my work with you! My time at the Sansonetti lab would not have been the same without the friendly atmosphere at PMM. I want to thank all my colleagues for their support, be it scientific discussions, technical help in the lab or mental with the beer after work. Especially I want to thank Emmanuel Sechet for his help in the last months, I could have never done all those Western Blots without him. Acknowledgements I would not have been here if it wasn’t for the EIMID ITN program, who gladly accepted me as a fellow. I enjoyed so much the international environment of this program. In this regard, I want to thank especially Marco Bargagna, who was always helpful and supportive, when it came to organizational things and deliverables. Also I want to thank the great group of EIMID fellows, who really made these years of my PhD special and with whom I enjoyed so many great times all around Europe. I also want to thank my friends in Paris, especially the 12:30 lunch gang. Everybody knows that science is a tough street and that especially during a PhD some breaking points are reached. Thankfully I had a great support from my friends here at Pasteur and I will never forget the times we shared in the ville de lumières. A special thanks goes to Mathieu, who shared a very special year with me, and who has always was a great support and source for laughter and good times. My family deserves a great round of applause for always supporting me during all my university education, morally and financially. I cannot thank you enough. I would not be here today if it wasn’t for my Mum, Meikel, my uncle Dieter and my dearly missed grandparents. This PhD title essentially goes to you! List of Abbreviations List of Abbreviations 1,25D3 – 1,25-dihydroxyvitamin D3 AD – Atopic dermatitis AMP – Antimicrobial peptide ANG4 – Angiogenin 4 AP1 – Activator protein 1 APC – Antigen-resenting cell APRIL – A proliferation-inducing ligand ARE – Apical recycling endosome ATF2 – Activating transcription factor 2 ATG16L1 – Autophagy related 16 like 1 ATP – Adenosine triphosphate BAFF – B-cell activating factor BMK – Big mitogen-activated protein kinase Brd4 – Bromodomain-containing protein 4 CAMP – Cathelicidin antimicrobial peptide CBP – cAMP-responsive element binding protein-binding protein CCL20 – CC-chemokine ligand 20 CCR6 – CC-chemokine receptor 6 CD – Crohn’s disease CDK9 – Cyclin-dependent kinase 9 CDRE – Caudal responsive element CFTR – Cystic fibrosis transmembrane conductance regulator CHD – Chromodomain-helicase-DNA-binding protein CNV – Copy number variation CNS1 – Conserved non-coding sequence 1 COPD – Chronic obstructive pulmonary disease CRAMP – Cathelin-related antimicrobial peptide CREB – Cyclic-AMP response element-binding protein CRS – Cryptdins-related sequence CTD – Carboxy‐terminal domain CTLA-4 – Cytotoxic T-lymphocyte antigen 4 CXCR4 – C-X-C chemokine receptor type 4 DC – Dendritic cell List of Abbreviations DEFB1 – Human beta defensin 2 DEFB2 – Human beta defensin 2 DEFB3 – Human beta defensin 3 DEFB4 – Human beta defensin 4 DNA – Deoxyribonucleic acid DNMT – DNA methyltransferases E. coli – Escherichia coli E. faecalis – Enterococcus faecalis EGFR – Epithelial growth factor receptor ER – Estrogen receptor ERE – Estrogen-responsive element ERK – Extracellular signal-regulated kinase FAE – Follicle-associated epithelia FliC – Flagella filament structural protein FOXO – Forkhead box transcription factor Foxp3 – Forkhead box P3 FRPL1 – Formyl peptide receptor-like 1 GALT – Gut-associated lymphoid tissue GAS – Group A Streptococcus GBS – Group B Streptococcus GCN5 – General control non-repressible synthesis 5 GNAT – GCN5-related N-acetyltransferases HAT – Histone acetyltransferase HBO1 – HAT bound to Orc1 hCAP18 – Human cationic antibacterial protein of 18 kDa HD 5 – Human alpha defensin 5 HD 6 – Human alpha defensin 6 HDAC – Histone deacetylase HDACi – HDAC inhibitor HDM – Histone demethylase HIF1 – Hypoxia inducible factor 1 HIP/PAP – Hepatointestinal pancreatic/pancreatitis‐ associated protein HIV – Human immunodeficiency virus HMT – Histone methyltransferase List of Abbreviations HNP – Human neutrophil peptide HOTAIR – Homeobox antisense intergenic RNA HPA axis – Hypothalamus–pituitary–adrenal axis H. pylori – Helicobacter pylori HSV – Herpes simplex virus HRE – HIF1 responsive element IAP – Intestinal alkaline phosphatase IBD – Inflammatory bowel disease IEC – Intestinal epithelial cell IEL – Intraepithelial lymphocyte IgA – Immunoglobulin A IgG – Immunoglobulin G IκBα – Inhibitor of NF-κB alpha IKK – IκB kinase IL8 – Interleukin 8 IL10 – Interleukin 10 IL1β – Interleukin 1 beta ILF – Isolated lymphoid follicles ILS – Insulin/insulin-like growth factor signaling Imd pathway – Immune deficiency pathway INF – Inflammatory gene IRAK – Interleukin-1 receptor-associated kinase IRF – Interferon response factor ISWI – Imitation SWI JDP – Jun dimerization protein JNK – c-Jun N-terminal kinases KCNN4 – Calcium-activated potassium channel protein 4 KDM2A – Lysine-specific demethylase 2A Lgr5 – Leucine-rich repeat-containing G-protein coupled receptor 5 lincRNA – Large multi-exonic intervening non-coding RNA LINoCR – LPS-inducible non-coding RNA L. monocytogenes – Listeria monocytogenes LPS – Lipopolysaccharide LSD1 – Lysine-specific demethylase 1 LTi cells – Lymphoid tissue inducer cells List of Abbreviations mAchR – Muscarinic acetylcholine receptor MAL – MYD88-adaptor-like protein MAMP – Microbe-associated molecular pattern MAPK – Mitogen-activated protein kinase M cells – Microfold cells MCP – Macrophage attractant protein MDP – Muramyl dipeptide MLN – Mesenteric lymph node MOF – Males absent on the first MORF – MOZ-related factor MOZ – Monocytic leukemia zinc finger protein MSK – Mitogen- and stress activated protein kinase MSV – Multi site variations M. tuberculosis – Mycobacterium tuberculosis MUC-2 – Mucin 2 MYD88 – Myeloid differentiation primary response 88 nAchR – Nicotinic acetylcholine receptor NCoR – Nuclear receptor corepressor NEMO – NF-κB essential modulator NFAT – Nuclear factor of activated T-cells NF-κB – Nuclear factor kappa B NK – Natural killer NLR – NOD-like receptor NOD – Nucleotide-binding oligomerization domain containing protein NuRD – Nucleosome remodeling deacetylase p300 – E1A-associated protein of 300 kDa P. aeruginosa – Pseudomonas
Recommended publications
  • A Unique Structure at the Carboxyl Terminus of the Largest Subunit of Eukaryotic RNA Polymerase II (Transcription/Gene Expression/Protein Phosphorylation) JEFFRY L
    Proc. Natl. Acad. Sci. USA Vol. 82, pp. 7934-7938, December 1985 Biochemistry A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II (transcription/gene expression/protein phosphorylation) JEFFRY L. CORDEN*, DEBORAH L. CADENAt, JOSEPH M. AHEARN, JR.*, AND MICHAEL E. DAHMUSt *Howard Hughes Medical Institute Laboratory, Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; and tDepartment of Biochemistry and Biophysics, University of California, Davis, CA 95616 Communicated by Daniel Nathans, August 2, 1985 ABSTRACT Purified eukaryotic nuclear RNA polymerase alous mobility in NaDodSO4 gels due to postsynthetic mod- II consists of three subspecies that differ in the apparent ification cannot be ruled out. The three forms of the largest molecular masses of their largest subunit, designated Ho, Ha, subunit Ho (240 kDa), Iha (210-220 kDa), and lIb (170-180 and HIb for polymerase species HO, HA, and BIB, respectively. kDa) also differ in their ability to be phosphorylated both in Subunits Ho, Ha, and IHb are the products of a single gene. We vitro and in vivo (14). Subunit lIc (140 kDa) is structurally present here the amino acid composition of calf thymus different from IHo, Iha, and IIb (2, 33) and is present in all subunits Ha and lIb and the C-terminal amino acid sequence three forms of RNA polymerase II in equimolar stoichiom- of subunit Ha (Ho) inferred from the nucleotide sequence of etry with the largest subunit. part of the mouse gene encoding this RNA polymerase subunit. A monoclonal antibody prepared against calfthymus RNA The calculated amino acid composition ofthe peptide unique to polymerase II has been shown to recognize a determinant on subunit Ha indicates that subunit Ha contains a domain rich in subunit Iha (IIo) but not on IIb (15).
    [Show full text]
  • Overexpression of Salicylic Acid Carboxyl Methyltransferase (Cssamt1) Enhances Tolerance to Huanglongbing Disease in Wanjincheng Orange (Citrus Sinensis (L.) Osbeck)
    International Journal of Molecular Sciences Article Overexpression of Salicylic Acid Carboxyl Methyltransferase (CsSAMT1) Enhances Tolerance to Huanglongbing Disease in Wanjincheng Orange (Citrus sinensis (L.) Osbeck) Xiuping Zou * , Ke Zhao, Yunuo Liu, Meixia Du, Lin Zheng, Shuai Wang, Lanzhen Xu, Aihong Peng, Yongrui He, Qin Long and Shanchun Chen * Citrus Research Institute, Southwest University/Chinese Academy of Agricultural Sciences, Chongqing 400716, China; [email protected] (K.Z.); [email protected] (Y.L.); [email protected] (M.D.); [email protected] (L.Z.); [email protected] (S.W.); [email protected] (L.X.); [email protected] (A.P.); [email protected] (Y.H.); [email protected] (Q.L.) * Correspondence: [email protected] (X.Z.); [email protected] (S.C.) Abstract: Citrus Huanglongbing (HLB) disease or citrus greening is caused by Candidatus Liberibacter asiaticus (Las) and is the most devastating disease in the global citrus industry. Salicylic acid (SA) plays a central role in regulating plant defenses against pathogenic attack. SA methyltransferase (SAMT) modulates SA homeostasis by converting SA to methyl salicylate (MeSA). Here, we report on the functions of the citrus SAMT (CsSAMT1) gene from HLB-susceptible Wanjincheng orange Citation: Zou, X.; Zhao, K.; Liu, Y.; (Citrus sinensis (L.) Osbeck) in plant defenses against Las infection. The CsSAMT1 cDNA was Du, M.; Zheng, L.; Wang, S.; Xu, L.; expressed in yeast. Using in vitro enzyme assays, yeast expressing CsSAMT1 was confirmed to Peng, A.; He, Y.; Long, Q.; et al. specifically catalyze the formation of MeSA using SA as a substrate. Transgenic Wanjincheng orange Overexpression of Salicylic Acid plants overexpressing CsSAMT1 had significantly increased levels of SA and MeSA compared to Carboxyl Methyltransferase wild-type controls.
    [Show full text]
  • Lysis of Red Blood Cells and Alveolar Epithelial Toxicity by Therapeutic Pulmonary Surfactants
    0031-3998/95/3701-0026$03.0010 PEDIATRIC RESEARCH Vol. 37, No. 1, 1995 Copyright 0 1994 International Pediatric Research Foundation, Inc. Printed in U.S.A. Lysis of Red Blood Cells and Alveolar Epithelial Toxicity by Therapeutic Pulmonary Surfactants RICHARD D. FINDLAY, H. WILLIAM TAEUSCH, REMEDIOS DAVID-CU, AND FRANS J. WALTHER Division of Neonatology, Department of Pediatrics, Martin Luther King, Jr./Drew University Medical Center, UCLA School of Medicine, Los Angeles, Calijornia 90059 The risk of pulmonary hemorrhage is increased in extremely rats were treated with Survanta, Exosurf, the Exosurf compo- low birth weight infants treated with surfactant. The pathogenesis nents tyloxapol and hexadecanol, melittin, or culture medium of this increased risk is far from clear. We tested whether alone. After 24 h of incubation, lactate dehydrogenase release exposure of cell membranes to surfactant may lead to increased into the media was measured as a percent of total lactate dehy- membrane permeability, hypothesizing that this process may drogenase activity to indicate cytotoxicity. Lactate dehydroge- contribute to the occurrence of alveolar hemorrhage after surfac- nase release was <lo% for control experiments but increased tant treatment. Aliquots of washed packed red blood cells (used sharply with Exosurf and its components tyloxapol and hexade- as membrane model) were suspended in 0.9% NaCl with various canol. These results indicate that surfactant may be associated concentrations of Survanta or Exosurf for either 2 or 24 h at with in vitro cytotoxicity and that this property differs for dif- 37°C. Cytolysis was measured by spectrophotometric determi- ferent surfactants and different dosages. (Pediatr Res 37: 26-30, nation of free Hb after centrifugation.
    [Show full text]
  • Supplementary Figure S1 Functional Characterisation of Snmp:GFP
    doi: 10.1038/nature06328 SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE LEGENDS Figure S1 | Functional characterisation of SNMP fusion proteins. Dose-response curve for cVA in Or67d neurons of wild-type (Berlin), SNMP mutant (Or67d- GAL4/+;SNMP1/SNMP2), SNMP:GFP rescue (Or67d-GAL4/UAS- SNMP:GFP;SNMP1/SNMP2) and YFP(1):Or83b/SNMP:YFP(2) rescue (Or67d:GAL4,UAS-YFP(1):Or83b/UAS-SNMP:YFP(2);SNMP1,Or83b2/SNMP2,Or83b1 ) animals. Mean responses are plotted (± s.e.m; wild-type n=47, SNMP mutant n=46, SNMP:GFP rescue n=20; YFP(1):Or83b/SNMP:YFP(2) rescue n=22; ≤4 sensilla/animal, mixed genders). Wild-type and SNMP:GFP rescue responses to cVA are not significantly different (ANOVA; p>0.1175). YFP(1):Or83b/SNMP:YFP(2) rescue responses to cVA are highly significantly different from SNMP mutants and from wild- type (ANOVA; p<0.0001), indicating partial rescue. Figure S2 | Cell type-specific rescue of SNMP expression. a, Immunostaining for mCD8:GFP (anti-GFP, green) and LUSH (magenta) in LUSH-GAL4/UAS-mCD8:GFP animals reveals faithful recapitulation of endogenous expression by the LUSH-GAL4 driver. b, Two-colour RNA in situ hybridisation for SNMP (green) and Or67d (magenta) in antennal sections of wild-type, Or67d neuron SNMP rescue (Or67d-GAL4/UAS- SNMP;SNMP1/SNMP2) and support cell SNMP rescue (LUSH-GAL4/UAS- SNMP;SNMP1/SNMP2) animals. www.nature.com/nature 1 Benton et al., Figure S1 ) -1 wild-type 120 SNMP:GFP rescue 80 YFP(1):Or83b/SNMP:YFP(2) rescue 40 Corrected response (spikes s 0 SNMP-/- 0 0.1 1 10 100 cVA (%) www.nature.com/nature 2 Benton
    [Show full text]
  • Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Yazan H
    University of Arkansas, Fayetteville ScholarWorks@UARK Theses and Dissertations 8-2013 Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Yazan H. Akkam University of Arkansas, Fayetteville Follow this and additional works at: http://scholarworks.uark.edu/etd Part of the Biochemistry Commons, Medicinal and Pharmaceutical Chemistry Commons, and the Molecular Biology Commons Recommended Citation Akkam, Yazan H., "Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications" (2013). Theses and Dissertations. 908. http://scholarworks.uark.edu/etd/908 This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more information, please contact [email protected], [email protected]. Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Cell and Molecular Biology by Yazan H. Akkam Jordan University of Science and Technology Bachelor of Science in Pharmacy, 2001 Al-Balqa Applied University Master of Science in Biochemistry and Chemistry of Pharmaceuticals, 2005 August 2013 University of Arkansas This dissertation is approved for recommendation to the Graduate Council. Dr. David S. McNabb Dissertation Director Professor Roger E. Koeppe II Professor Gisela F. Erf Committee Member Committee Member Professor Ralph L. Henry Dr. Suresh K. Thallapuranam Committee Member Committee Member ABSTRACT Candida species are the fourth leading cause of nosocomial infection. The increased incidence of drug-resistant Candida species has emphasized the need for new antifungal drugs.
    [Show full text]
  • The Crosstalk: Exosomes and Lipid Metabolism
    Wang et al. Cell Communication and Signaling (2020) 18:119 https://doi.org/10.1186/s12964-020-00581-2 REVIEW Open Access The crosstalk: exosomes and lipid metabolism Wei Wang1,2†, Neng Zhu3†, Tao Yan1,2†, Ya-Ning Shi1,2, Jing Chen4, Chan-Juan Zhang1,2, Xue-Jiao Xie5, Duan-Fang Liao1,2* and Li Qin1,2* Abstract Exosomes have been considered as novel and potent vehicles of intercellular communication, instead of “cell dust”. Exosomes are consistent with anucleate cells, and organelles with lipid bilayer consisting of the proteins and abundant lipid, enhancing their “rigidity” and “flexibility”. Neighboring cells or distant cells are capable of exchanging genetic or metabolic information via exosomes binding to recipient cell and releasing bioactive molecules, such as lipids, proteins, and nucleic acids. Of note, exosomes exert the remarkable effects on lipid metabolism, including the synthesis, transportation and degradation of the lipid. The disorder of lipid metabolism mediated by exosomes leads to the occurrence and progression of diseases, such as atherosclerosis, cancer, non- alcoholic fatty liver disease (NAFLD), obesity and Alzheimer’s diseases and so on. More importantly, lipid metabolism can also affect the production and secretion of exosomes, as well as interactions with the recipient cells. Therefore, exosomes may be applied as effective targets for diagnosis and treatment of diseases. Keywords: Exosome, Lipid metabolism, Atherosclerosis, Cancer Background the membrane [8]. Similar to the cell membrane, the lipid Exosomes display cup-like shape of 30 ~ 100 nm in diam- bilayer protects exosome contents from various stimuli in eter, and are secreted by multi-type cells, such as nerve thecirculatingfluid.Therefore,somecontentsinexo- cells [1], natural killer cells [2, 3], cancer cells [4, 5]and somes are usually transported remotely in circulating body adipocytes [6].
    [Show full text]
  • IRON-REGULATORY FUNCTION of HEPCIDIN in the CHANNEL CATFISH and WESTERN CLAWED FROG Except Where Reference Is Made to the Work
    IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG Except where reference is made to the work of others, the work described in this dissertation is my own or was done in collaboration with my advisory committee. This dissertation does not include proprietary or classified information. __________________________ Xueyou Hu Certificate of Approval: __________________________ __________________________ Jishu Shi, Co-Chair Edward E. Morrison, Co-Chair Assistant Professor Professor Anatomy, Physiology and Anatomy, Physiology and Pharmacology Pharmacology __________________________ __________________________ Robert J. Kemppainen Christine C. Dykstra Professor Associate Professor Anatomy, Physiology and Pathobiology Pharmacology __________________________ __________________________ Yingzi Cong Joe F. Pittman Assistant Professor Interim Dean Medicine Graduate School IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG Xueyou Hu A Dissertation Submitted to the Graduate Faculty of Auburn University in Partial Fulfillment of the Requirement for the Degree of Doctor of Philosophy Auburn, Alabama May 10, 2008 IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG XUEYOU HU Permission is granted to Auburn University to make copies of this dissertation at its discretion, upon request of individuals or institutions at their expense. The author reserves all publication rights. ______________________________ Signature of Author ______________________________ Date
    [Show full text]
  • Regeneron Science Talent Search 2021 Scholars 2021 Scholars
    REGENERON SCIENCE TALENT SEARCH 2021 SCHOLARS 2021 SCHOLARS The Regeneron Science Talent Search (Regeneron STS), a program of Society for Science, is the nation’s most prestigious science and math competition for high school seniors. Alumni of STS have made extraordinary contributions to science and hold more than 100 of the world’s most distinguished science and math honors, including the Nobel Prize and the National Medal of Science. Each year, 300 Regeneron STS scholars and their schools are recognized. From that select pool of scholars, 40 student finalists are invited to participate in final judging, display their work to the public, meet with notable scientists and compete for awards, including the top award of $250,000. Regeneron Science Talent Search, A Program of Society for Science ARIZONA Scottsdale BASIS Scottsdale Mehta, Viraj, 18 GLIA-Deep: Glioblastoma Image Analysis Using Deep Learning Convolutional Neural Networks to Accurately Classify Gene Methylation and Predict Drug Effectiveness CALIFORNIA Arcadia Arcadia High School Liu, Stanley Cheung, 17 A Microfluidic Device for Blood Plasma Separation and Fluorescence Detection of Biomarkers Using Acoustic Microstreaming Atherton Menlo School Tung, Katherine, 17 The Sperner Property for 132-Avoiding Intervals in the Weak Order Cupertino Cupertino High School Agrawal, Vardhan, 18 BP-Lytic: A Novel Apparatus to Continuously, Cufflessly, and Affordably Monitor Blood Pressure Trends Homestead High School Sanyal, Anushka, 17 Intronic RNA Lariats Protect Against Neurodegenerative Disease
    [Show full text]
  • Optimizing Exogenous Surfactant As a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2
    Lawrence Berkeley National Laboratory Recent Work Title Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2. Permalink https://escholarship.org/uc/item/9bk2h47d Journal Scientific reports, 10(1) ISSN 2045-2322 Authors Baer, Brandon Veldhuizen, Edwin JA Molchanova, Natalia et al. Publication Date 2020-06-10 DOI 10.1038/s41598-020-66448-1 Peer reviewed eScholarship.org Powered by the California Digital Library University of California www.nature.com/scientificreports OPEN Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2 Brandon Baer1 ✉ , Edwin J. A. Veldhuizen2, Natalia Molchanova3,4, Shehrazade Jekhmane5, Markus Weingarth5, Håvard Jenssen3, Jennifer S. Lin6, Annelise E. Barron6, Cory Yamashita1,7 & Ruud Veldhuizen1,7 The rising incidence of antibiotic-resistant lung infections has instigated a much-needed search for new therapeutic strategies. One proposed strategy is the use of exogenous surfactants to deliver antimicrobial peptides (AMPs), like CATH-2, to infected regions of the lung. CATH-2 can kill bacteria through a diverse range of antibacterial pathways and exogenous surfactant can improve pulmonary drug distribution. Unfortunately, mixing AMPs with commercially available exogenous surfactants has been shown to negatively impact their antimicrobial function. It was hypothesized that the phosphatidylglycerol component of surfactant was inhibiting AMP function and that an exogenous surfactant, with a reduced phosphatidylglycerol composition would increase peptide mediated killing at a distal site. To better understand how surfactant lipids interacted with CATH-2 and afected its function, isothermal titration calorimetry and solid-state nuclear magnetic resonance spectroscopy as well as bacterial killing curves against Pseudomonas aeruginosa were utilized. Additionally, the wet bridge transfer system was used to evaluate surfactant spreading and peptide transport.
    [Show full text]
  • Magainin 2 in Action: Distinct Modes of Membrane Permeabilization in Living Bacterial and Mammalian Cells
    Biophysical Journal Volume 95 December 2008 5757–5765 5757 Magainin 2 in Action: Distinct Modes of Membrane Permeabilization in Living Bacterial and Mammalian Cells Yuichi Imura, Naoki Choda, and Katsumi Matsuzaki Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-Ku, Kyoto 606-8501, Japan ABSTRACT Interactions of cationic antimicrobial peptides with living bacterial and mammalian cells are little understood, although model membranes have been used extensively to elucidate how peptides permeabilize membranes. In this study, the interaction of F5W-magainin 2 (GIGKWLHSAKKFGKAFVGEIMNS), an equipotent analogue of magainin 2 isolated from the African clawed frog Xenopus laevis, with unfixed Bacillus megaterium and Chinese hamster ovary (CHO)-K1 cells was investigated, using confocal laser scanning microscopy. A small amount of tetramethylrhodamine-labeled F5W-magainin 2 was incorporated into the unlabeled peptide for imaging. The influx of fluorescent markers of various sizes into the cytosol revealed that magainin 2 permeabilized bacterial and mammalian membranes in significantly different ways. The peptide formed pores with a diameter of ;2.8 nm (, 6.6 nm) in B. megaterium, and translocated into the cytosol. In contrast, the peptide significantly perturbed the membrane of CHO-K1 cells, permitting the entry of a large molecule (diameter, .23 nm) into the cytosol, accompanied by membrane budding and lipid flip-flop, mainly accumulating in mitochondria and nuclei. Adenosine triphosphate and negatively charged glycosaminoglycans were little involved in the magainin-induced permeabilization of membranes in CHO-K1 cells. Furthermore, the susceptibility of CHO-K1 cells to magainin was found to be similar to that of erythrocytes. Thus, the distinct membrane-permeabilizing processes of magainin 2 in bacterial and mammalian cells were, to the best of our knowledge, visualized and characterized in detail for the first time.
    [Show full text]
  • Interactions Between APOBEC3 and Murine Retroviruses: Mechanisms of Restriction and Drug Resistance
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2013 Interactions Between APOBEC3 and Murine Retroviruses: Mechanisms of Restriction and Drug Resistance Alyssa Lea MacMillan University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Virology Commons Recommended Citation MacMillan, Alyssa Lea, "Interactions Between APOBEC3 and Murine Retroviruses: Mechanisms of Restriction and Drug Resistance" (2013). Publicly Accessible Penn Dissertations. 894. https://repository.upenn.edu/edissertations/894 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/894 For more information, please contact [email protected]. Interactions Between APOBEC3 and Murine Retroviruses: Mechanisms of Restriction and Drug Resistance Abstract APOBEC3 proteins are important for antiretroviral defense in mammals. The activity of these factors has been well characterized in vitro, identifying cytidine deamination as an active source of viral restriction leading to hypermutation of viral DNA synthesized during reverse transcription. These mutations can result in viral lethality via disruption of critical genes, but in some cases is insufficiento t completely obstruct viral replication. This sublethal level of mutagenesis could aid in viral evolution. A cytidine deaminase-independent mechanism of restriction has also been identified, as catalytically inactive proteins are still able to inhibit infection in vitro. Murine retroviruses do not exhibit characteristics of hypermutation by mouse APOBEC3 in vivo. However, human APOBEC3G protein expressed in transgenic mice maintains antiviral restriction and actively deaminates viral genomes. The mechanism by which endogenous APOBEC3 proteins function is unclear. The mouse provides a system amenable to studying the interaction of APOBEC3 and retroviral targets in vivo.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,829,086 B2 Hilbert Et Al
    US007829086B2 (12) United States Patent (10) Patent No.: US 7,829,086 B2 Hilbert et al. (45) Date of Patent: Nov. 9, 2010 (54) HUMANIZED ANTI-CD22 ANTIBODIES AND 2004/0202658 A1 10/2004 Benyunes THEIR USE IN TREATMENT OF 2004/021915.6 A1 11/2004 Goldenberg et al. ONCOLOGY, TRANSPLANTATION AND 2005, 0118182 A1 6/2005 Pastan et al. AUTOIMMUNE DISEASE 2007,0264260 A1 11/2007 Tuscano et al. (75) Inventors: David M. Hilbert, Bethesda, MD (US); 2008.0118505 A1 5/2008 Tedder Tarran Jones, Radlett (GB); David G. Williams, Epsom (GB) (73) Assignees: Medimmune, LLC, Gaithersburg, MD FOREIGN PATENT DOCUMENTS (US); Aeres Biomedical, Ltd., London EP O 660 721 B1 10, 2008 (GB) WO WOO3,O93320 A2 11/2003 (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 U.S.C. 154(b) by 132 days. OTHER PUBLICATIONS (21) Appl. No.: 11/715,308 MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).* De Pascalis et al. (The Journal of Immunology (2002) 169, 3076 (22) Filed: Mar. 6, 2007 3084).* (65) Prior Publication Data Casset et al. (2003) BBRC 307, 198-205).* Vajdos et al. (2002) J. Mol. Biol. 320, 415-428).* US 2007/O258981 A1 Nov. 8, 2007 Holmetal ((2007) Mol. Immunol. 44: 1075-1084).* Related U.S. Application Data Chen et al. (J. Mol. Bio. (1999) 293, 865-881).* Wu et al. (J. Mol. Biol. (1999) 294, 151-162).* (60) Provisional application No. 60/779,806, filed on Mar. Brummell et al. (Biochemistry 32:1180-1187 (1993)).* 6, 2006.
    [Show full text]